States have proven to be innovators on prescription drug pricing policy so far, and policy watchers expect aggressive action in 2019. Several incoming Democratic governors made drug pricing a campaign issue, attorneys general are suing drug makers and defending drug pricing laws in court, and state legislators are planning to introduce new bills in upcoming legislative sessions. The following is a special rundown by Inside Drug Pricing of drug-pricing activity expected at the state-level in the new year. Legislation...